Zobrazeno 1 - 10
of 352
pro vyhledávání: '"Holgersson G"'
Autor:
Nilsson J; Center for Research & Development, Uppsala University/ County Council of Gävleborg, Gävle Hospital, Gävle, Sweden.; Department of Radiation Sciences & Oncology, Umeå University Hospital, Umeå, Sweden.; Department of Radiology, Gävle Hospital, Gävle, Sweden., Bergström S; Center for Research & Development, Uppsala University/ County Council of Gävleborg, Gävle Hospital, Gävle, Sweden., Hållberg H; EpiStat, Uppsala, Sweden., Berglund A; EpiStat, Uppsala, Sweden., Bergqvist M; Department of Radiation Sciences & Oncology, Umeå University Hospital, Umeå, Sweden.; Department of Immunology Genetics and Pathology, Section of clinical and experimental oncology, Uppsala University Hospital, Uppsala, Sweden., Holgersson G; Department of Immunology Genetics and Pathology, Section of clinical and experimental oncology, Uppsala University Hospital, Uppsala, Sweden.
Publikováno v:
The American journal of hospice & palliative care [Am J Hosp Palliat Care] 2024 Sep; Vol. 41 (9), pp. 969-977. Date of Electronic Publication: 2023 Nov 06.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Haakensen, V. D., Horndalsveen, H., Nymoen, H. M., Holgersson, G., Land, L. Holm, Koivunen, J., Cicenas, S., Oselin, K., Madebo, T., Van Helvoirt, R., Helbekkmo, N., Gronberg, B. H., Aanerud, M., Rogg, L., Helland, A.
Publikováno v:
Haakensen, V D, Horndalsveen, H, Nymoen, H M, Holgersson, G, Land, L H, Koivunen, J, Cicenas, S, Oselin, K, Madebo, T, Van Helvoirt, R, Helbekkmo, N, Gronberg, B H, Aanerud, M, Rogg, L & Helland, A 2021, ' Durvalumab After chemoRadioTherapy (DART) for NSCLC Patients-a Phase II Translational and Biomarker Study ', Journal of Thoracic Oncology, vol. 16, no. 3, Suppl., pp. S351-S352 . https://doi.org/10.1016/j.jtho.2021.01.555
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::722dc1a1b82f2a91c36899e39b50d681
https://portal.findresearcher.sdu.dk/da/publications/cf7e3eb5-03a9-4c72-9e53-a07ff7ef0367
https://portal.findresearcher.sdu.dk/da/publications/cf7e3eb5-03a9-4c72-9e53-a07ff7ef0367
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S1237-S1237
Autor:
Källman M; Department of Radiation Sciences, Umeå University, Umeå, Sweden. mikael.kallman@umu.se.; Centre for Research and Development, Uppsala University/Region Gävleborg, Gävle, Sweden. mikael.kallman@umu.se.; Department of Oncology, Gävle Hospital, Gävle, Sweden. mikael.kallman@umu.se., Bergström S; Department of Radiation Sciences, Umeå University, Umeå, Sweden.; Centre for Research and Development, Uppsala University/Region Gävleborg, Gävle, Sweden.; Department of Oncology, Gävle Hospital, Gävle, Sweden., Carlsson T; Department of Oncology, Gävle Hospital, Gävle, Sweden., Järås J; JRS Statistics AB, Stockholm, Sweden., Holgersson G; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden., Nordberg JH; Regional Cancer Centre Stockholm-Gotland, Stockholm, Sweden.; Department of NVS, Karolinska Institution, Stockholm, Sweden.; Department of Physiology & Pharmacology, Karolinska Institution, Stockholm, Sweden., Nilsson J; Department of Radiation Sciences, Umeå University, Umeå, Sweden.; Centre for Research and Development, Uppsala University/Region Gävleborg, Gävle, Sweden., Wode K; Department of Radiation Sciences, Umeå University, Umeå, Sweden.; Regional Cancer Centre Stockholm-Gotland, Stockholm, Sweden.; Department of Nursing, Umeå University, Umeå, Sweden., Bergqvist M; Department of Radiation Sciences, Umeå University, Umeå, Sweden.
Publikováno v:
BMC complementary medicine and therapies [BMC Complement Med Ther] 2023 Feb 16; Vol. 23 (1), pp. 51. Date of Electronic Publication: 2023 Feb 16.
Autor:
Haakensen, V.D., Horndalsveen, H., Nymoen, H.M., Holgersson, G., Land, L. Holm, Koivunen, J., Cicenas, S., Oselin, K., Madebo, T., Van Helvoirt, R., Helbekkmo, N., Grønberg, B.H., Aanerud, M., Rogg, L., Helland, Å.
Publikováno v:
In Journal of Thoracic Oncology March 2021 16(3) Supplement:S351-S352
Autor:
Moons, Louana1,2 (AUTHOR), Ombelet, Fouke3,4,5 (AUTHOR), Deschodt, Mieke6 (AUTHOR) mieke.deschodt@kuleuven.be, De Roo, Maaike L.1,7 (AUTHOR), Oldenburger, Eva2,8 (AUTHOR), Bossuyt, Inge2 (AUTHOR), Pype, Peter9 (AUTHOR)
Publikováno v:
PLoS ONE. 11/11/2024, Vol. 19 Issue 11, p1-12. 12p.
Autor:
Nilsson J; Center for Research & Development, Uppsala University/ County Council of Gävleborg, Gävle Hospital, Gävle, Sweden. kjnilsson@live.se.; Department of Radiation Sciences Umeå University Hospital, Umeå, Sweden. kjnilsson@live.se.; Department of Radiology, Gävle Hospital, Gävle, Sweden. kjnilsson@live.se., Holgersson G; Department of Immunology Genetics and Pathology, Section of clinical and experimental oncology, Uppsala University Hospital, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, 751 85, Uppsala, Sweden., Ullenhag G; Department of Immunology Genetics and Pathology, Section of clinical and experimental oncology, Uppsala University Hospital, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, 751 85, Uppsala, Sweden., Holmgren M; Center for Research & Development, Uppsala University/ County Council of Gävleborg, Gävle Hospital, Gävle, Sweden.; Department of Oncology, Gävle Hospital, Gävle, Sweden., Axelsson B; Department of Radiation Sciences Umeå University Hospital, Umeå, Sweden.; Unit of Clinical research center, Östersund, Sweden., Carlsson T; Center for Research & Development, Uppsala University/ County Council of Gävleborg, Gävle Hospital, Gävle, Sweden., Bergqvist M; Center for Research & Development, Uppsala University/ County Council of Gävleborg, Gävle Hospital, Gävle, Sweden.; Department of Radiation Sciences Umeå University Hospital, Umeå, Sweden.; Department of Oncology, Gävle Hospital, Gävle, Sweden., Bergström S; Center for Research & Development, Uppsala University/ County Council of Gävleborg, Gävle Hospital, Gävle, Sweden.; Department of Radiation Sciences Umeå University Hospital, Umeå, Sweden.; Department of Oncology, Gävle Hospital, Gävle, Sweden.
Publikováno v:
BMC palliative care [BMC Palliat Care] 2021 Mar 14; Vol. 20 (1), pp. 43. Date of Electronic Publication: 2021 Mar 14.
Autor:
Nilsson J; Center for Research & Development, Uppsala University/County Council of Gävleborg, Gävle Hospital, Gävle, Sweden jonas.nilsson@regiongavleborg.se.; Department of Radiation Sciences & Oncology, Umeå University Hospital, Umeå, Sweden.; Department of Radiology, Gävle Hospital, Gävle, Sweden., Axelsson B; Department of Radiation Sciences & Oncology, Umeå University Hospital, Umeå, Sweden.; Department of Radiation Sciences, Unit of Clinical Research Centre - Östersund, Umeå University, Umeå, Sweden., Holgersson G; Department of Immunology, Genetics and Pathology (IGP) Uppsala University, Uppsala, Sweden., Carlsson T; Center for Research & Development, Uppsala University/County Council of Gävleborg, Gävle Hospital, Gävle, Sweden., Bergqvist M; Center for Research & Development, Uppsala University/County Council of Gävleborg, Gävle Hospital, Gävle, Sweden.; Department of Radiation Sciences & Oncology, Umeå University Hospital, Umeå, Sweden.; Department of Oncology, Gävle Hospital, Gävle, Sweden., Bergstrom S; Center for Research & Development, Uppsala University/County Council of Gävleborg, Gävle Hospital, Gävle, Sweden.; Department of Radiation Sciences & Oncology, Umeå University Hospital, Umeå, Sweden.
Publikováno v:
Anticancer research [Anticancer Res] 2020 Jul; Vol. 40 (7), pp. 3897-3903.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.